What kind of doctor actually treats perimenopause, and what is worth checking before you choose one?

Menopause specialist, gynecologist or internist: who does what?

A gynecologist manages the reproductive system and is the natural home for bleeding problems, contraception through the transition, pelvic and vaginal symptoms, and anything that needs an examination or an ultrasound. An internal medicine physician, sometimes called an internist, manages the adult body as a whole and is the natural home when perimenopause arrives alongside thyroid change, rising blood pressure or cholesterol, blood sugar drift, sleep problems, joint pain or several medications at once. A family physician covers similar ground across the whole family. A menopause specialist is not a separate specialty; it is a clinician from one of these backgrounds who has taken the transition on as a focus. Some hold a menopause-care certification from The Menopause Society, which signals dedicated study and an examination in this area; it sits on top of a licence and a specialty rather than replacing them.

In practice the right choice depends on what dominates the picture. Heavy or erratic bleeding and pelvic symptoms point toward a gynecologist. Fatigue, weight change, palpitations, brain fog, broken sleep and mood change overlap with thyroid, iron and blood sugar problems, and point toward a physician who will look at the whole picture and rule those in or out before attributing everything to hormones. Many women are best served by both: a gynecologist for the pelvic side and an internist holding the systems view, with the two coordinating.

What does a good first visit cover?

A good first visit is mostly conversation. It covers the cycle history month by month over the past year or two, which symptoms cluster together and when they started, sleep, mood, hot flashes and night sweats, the bleeding pattern, sexual and urinary symptoms, the weight trajectory, every medication and supplement, and the personal and family history that shapes treatment choices: blood clots, stroke, heart disease, breast and other hormone-sensitive cancers, migraine, liver disease and bone health. During the transition roughly 50 to 75 percent of women have hot flashes or night sweats [PMID: 36749328], and for more than half of those with frequent symptoms they last more than seven years [PMID: 25686030], so the visit also asks what the symptoms cost in sleep, work and relationships, because that cost is what any treatment is weighed against.

The physical side is brief: blood pressure, weight and waist, and an examination when the symptoms call for one. Blood tests are chosen from the history rather than ordered as a package, for reasons the testing section below explains. The visit should end with a shared understanding of what is probably happening, what would confirm or change that view, what the options are, and when the next conversation happens. A visit that ends with a treatment and no plan, or with tests and no explanation of what they are for, has skipped the part that matters.

How are treatment decisions made?

Treatment decisions rest on symptoms, history and preference, not on a hormone level. The options fall into three groups: hormone therapy, non-hormonal treatments, and the lifestyle foundations that make everything else work better. Hormone therapy remains the most effective treatment for hot flashes and night sweats and for the genitourinary symptoms of menopause, and it prevents bone loss; its risks depend on the type, dose, route, duration and timing of use and on whether a progestogen is included [PMID: 35797481]. On average it cuts hot flash frequency by about three quarters [PMID: 36749328].

The 2002 findings of the Women's Health Initiative led to a steep fall in hormone therapy use; the later analyses of the same trials showed that the balance of benefit and risk depended heavily on age and time since menopause, a lesson that was largely lost in the noise at the time [PMID: 33858012]. The current position of the specialty societies is that for women under 60 or within ten years of menopause who have no contraindications, the balance is favorable for treating bothersome symptoms and preventing bone loss, with periodic re-evaluation of whether to continue [PMID: 35797481].

Non-hormonal options have real evidence too. Cognitive behavioral therapy, clinical hypnosis, certain antidepressants, a nerve-pain medication and a newer class of medication that acts on the brain's temperature-control circuitry are all recommended for hot flashes by the specialty society's evidence review, while most supplements and herbal remedies are not [PMID: 37252752]. The better-studied non-hormonal medications reduce hot flash frequency by roughly 40 to 65 percent [PMID: 36749328]. Lifestyle is not a consolation prize: sleep, alcohol, resistance training, protein and blood sugar control shape what the transition does to weight, bone, muscle and long-term cardiovascular and metabolic risk, whichever symptom treatment is chosen.

Which hormone therapy is best for perimenopause?

There is no single best hormone therapy for perimenopause; there is the right one for a particular woman, chosen on symptoms, history, stage of the transition and preference. The decisions a physician walks through are estrogen alone or combined with a progestogen (a progestogen is included when the uterus is present, to protect its lining), estrogen through the skin or by mouth, which estrogen and which progestogen, a sequential regimen that mimics a cycle or a continuous one, and dose and duration [Source: NICE 2026 Menopause: identification and management NG23]. Skin and oral estrogen work about equally well for hot flashes [PMID: 36749328], but the route changes the risk profile [PMID: 35797481], and the guideline steers toward the skin route when the risk of clots is raised, including with a body mass index over 30 [Source: NICE 2026 Menopause: identification and management NG23].

Perimenopause has a wrinkle of its own: the ovaries are still producing hormones, erratically, so a regimen has to sit alongside that output rather than replace a level that has already settled. That is why sequential regimens, or hormonal contraception used for cycle and symptom control, come up in perimenopause in a way they do not years after the final period. Low-dose vaginal estrogen treats dryness, pain with sex and recurrent urinary symptoms with minimal absorption into the body, and can be used on its own or alongside systemic therapy [Source: NICE 2026 Menopause: identification and management NG23]. Testosterone is considered for low sexual desire when hormone therapy alone has not helped [Source: NICE 2026 Menopause: identification and management NG23]. On the word natural: the regulated body-identical hormones are the same molecules the ovary makes, while the efficacy and safety of unregulated compounded preparations are unknown, which is the guideline's own wording [Source: NICE 2026 Menopause: identification and management NG23].

Who is a good candidate for hormone therapy, and who should not take it?

A good candidate is a woman with bothersome symptoms who is under 60 or within ten years of menopause and has no contraindications; for her, the benefit-risk balance is favorable [PMID: 35797481]. Age alone is not a cut-off, but starting more than ten years after menopause or after 60 carries greater absolute risks of coronary heart disease, stroke, blood clots and dementia, so the conversation at 65 is a different conversation, and that is one reason hormone therapy is not used as a way to prevent dementia [PMID: 35797481]. Questions about memory and brain fog are answered in context rather than with a reflex: sleep, hot flashes, mood, thyroid and iron are each checked, because each can produce the same symptoms.

The situations that call for a specialist's judgment, and sometimes for a different route or a non-hormonal path, are a personal history of breast cancer or a high risk of it, a personal history of heart disease or stroke, and a high risk of blood clots; the guideline asks that these women be seen by a clinician with expertise in menopause rather than simply told no [Source: NICE 2026 Menopause: identification and management NG23]. Estrogen-dependent cancers and cardiovascular disease are the classic contraindications, and for these women the non-hormonal options matter most [PMID: 37252752]. The other standard cautions are unexplained vaginal bleeding, which needs its own evaluation first, and active liver disease. Type 2 diabetes is not a contraindication; it calls for the other conditions to be weighed [Source: NICE 2026 Menopause: identification and management NG23]. Migraine history is part of the same conversation. The candidacy question is answered by history, not by a test, which is why the first visit is mostly conversation.

Which tests help, which do not, and when in the cycle?

In a woman over 45 with the typical symptoms and a changed cycle, no blood test is needed to identify perimenopause, and the guideline advises against using estradiol, AMH or ovarian ultrasound to identify the transition at that age [Source: NICE 2026 Menopause: identification and management NG23]. FSH, the pituitary's signal to the ovaries, swings from month to month during the transition, so a single value can read normal in a responsive month and menopausal a few weeks later; the guideline considers it to confirm menopause only between 40 and 45 with symptoms, or under 40 when premature ovarian insufficiency is suspected, and not at all in someone using combined hormonal contraception, which suppresses it [Source: NICE 2026 Menopause: identification and management NG23]. The staging system used in research is built on the bleeding pattern, with hormone markers as supporting information [PMID: 22344196].

The tests that help are the ones that answer a different question. Timing matters for the hormone tests that are worth doing: when a woman is still cycling, FSH and estradiol are read at their baseline in the first days of a period, and progesterone about a week after ovulation, roughly a week before the next period is due, to show whether that cycle ovulated. Off-cycle draws produce numbers with nothing to compare them against. The markers that explain the same symptoms from outside the ovary are the ones a physician rarely skips: a full thyroid panel, since thyroid disease produces the same fatigue, sleep disruption, cycle change and mood shift; ferritin with a complete iron panel, because heavier periods drain iron and low iron mimics hormonal symptoms; fasting insulin with glucose and HbA1c, because midlife insulin resistance shares much of the picture and interacts with the transition; a lipid panel, because cardiovascular risk shifts around menopause; and vitamin D with a bone density scan when bone risk is in play.

Bleeding that returns after twelve months without a period, bleeding between periods that persists, or bleeding heavy enough to soak through protection hour after hour needs prompt evaluation, not a hormone panel.

What is worth checking in any physician?

Four things, and none of them is the specialty on the door.

• Training you can verify. A licence in the patient's state and board certification in a specialty, such as internal medicine or obstetrics and gynecology. Both can be confirmed through the state medical board and the certifying board's public directory. A menopause certification is a welcome addition, checked the same way.
• A reason for every test. Each test should answer a question that changes the plan. A fixed panel can be a useful starting point; the question is what happens with the result, and a clear answer to what a test would change is the tell.
• Accountability for the plan. A physician who can order and interpret testing, take responsibility for treatment decisions, including hormone therapy and the review of its benefits and risks over time, and work alongside the patient's other doctors.
• Time between visits. Perimenopause changes month to month. Ask what happens between appointments, who answers when a result comes back or a regimen needs adjusting, and how often the plan is reviewed.

Two more questions belong specifically to this transition: whether the physician is comfortable discussing hormone therapy with numbers rather than a reflex in either direction, and whether the symptoms that overlap with thyroid, iron and blood sugar problems get checked rather than assumed.

How do you find a perimenopause specialist near you, or online?

The nearest clinician is not always the right one, and the right one no longer has to be nearby. For care that depends on conversation, history and blood work, geography matters less than it once did. A physician who practices by video takes the full history on screen, orders blood work drawn at a laboratory near the patient, books any imaging or bone density scan at a center near her, reviews the results with her on screen, and coordinates with her local gynecologist or primary care physician when an examination, a procedure or a hands-on assessment is needed. Wherever in the country the patient lives, the workup is the same.

The menopause societies publish directories of clinicians who hold their certification, and a search by name on the state medical board confirms a licence in a minute. Whether the clinician is across town or across the country, the four checks above are what separate a good fit from a convenient one; distance is the least informative thing about a doctor.

How do you start?

Care at Extend Medical starts with the Work with Dr. Paul form; an email with the next steps follows. The practice is private-pay, not billed through insurance. The first conversation is the history described above, in full: the cycle, the symptoms and when they started, every medication, what has already been tried, and what feeling well would look like.

The deeper picture

Perimenopause is the one transition in adult medicine that touches every system at once, and it arrives at the age when thyroid disease, insulin resistance, iron loss and cardiovascular risk are also shifting. The clinical work is telling those apart, treating what is treatable, and using the transition as the moment the long-term plan gets written: bone, heart, metabolism and brain, not only hot flashes. A physician who reads the whole picture treats the symptoms in front of her and the decades ahead of them.